National Heart, Lung, and Blood Institute (NHLBI)
4,179
491
679
3,042
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.6%
274 terminated/withdrawn out of 4179 trials
91.7%
+5.2% vs industry average
12%
501 trials in Phase 3/4
34%
1032 of 3042 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (4179)
Hot Flashes and Neurovascular Function in Women
Role: collaborator
Reducing Disparities in Cardiovascular Health in Community Mental Health Settings: Optimizing Implementation Strategies
Role: collaborator
NHLBI-Emory Advanced Cardiac CT Reconstruction
Role: lead
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
Role: lead
A Clinical Trial to Study the Feasibility and Acceptability of an App to Support Pediatric Resuscitation
Role: collaborator
Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy
Role: lead
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
Role: collaborator
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Role: lead
Medication Adherence Program
Role: collaborator
Statins to Prevent Cancer Associated Blood Clots
Role: collaborator
Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers
Role: lead
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies
Role: lead
EDEN Intracardiac Electrogram Recording and Classifying System
Role: lead
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
Role: collaborator
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Role: lead
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
Role: lead
NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study
Role: lead
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Role: lead
Human Cerebral Blood Flow Regulation
Role: collaborator
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
Role: lead